Da Fu | Health Professions | Outstanding Scientist Award

 

Outstanding Scientist Award

Da Fu
Shanghai Jiao Tong University

Da Fu
Affiliation Shanghai Jiao Tong University
Country China
Scopus ID 59587646900
Documents 15
Citations 703
h-index 13
Subject area Health Professions
Event International Invention Awards

The Outstanding Scientist Award recognizes researchers whose scholarly contributions, research productivity, and demonstrated impact advance scientific knowledge and professional practice. This article presents the supplied academic profile of Da Fu, affiliated with Shanghai Jiao Tong University in China, and summarizes the bibliometric information provided for consideration in connection with the International Invention Awards. The profile is intended as an informational overview; the listed metrics and affiliation should be verified against current institutional and bibliographic records before being used for formal award decisions.[1]

Abstract

This article presents a bibliometric and academic overview of Da Fu, identified in the supplied information as a researcher affiliated with Shanghai Jiao Tong University, China. The profile lists 15 documents, 703 citations, and an h-index of 13 in the subject area of Health Professions, alongside Scopus Author ID 59587646900. These indicators provide a preliminary snapshot of research output and citation visibility, but they do not independently establish research quality, originality, or individual contribution. The article outlines the profile’s academic context, potential research significance, and relevance to the Outstanding Scientist Award associated with the International Invention Awards. Independent verification of the affiliation, publications, and current metrics remains necessary before formal evaluation or publication.[2]

Keywords

Outstanding Scientist Award; Da Fu; Shanghai Jiao Tong University; China; Health Professions; research evaluation; bibliometrics; Scopus author profile; citation analysis; scientific recognition; International Invention Awards.[1]

Introduction

Scientific recognition programs acknowledge contributions to research, innovation, and the development of knowledge within professional disciplines. The Outstanding Scientist Award provides a framework for presenting a researcher’s academic record and considering its significance through transparent evaluation. Bibliographic databases such as Scopus support the discovery and analysis of scholarly publications and citation relationships, although database indicators should be interpreted alongside the content and context of the underlying research. [1]

Research Profile

The associated Scopus Author ID is 59587646900. The submitted bibliometric figures list 15 documents, 703 citations, and an h-index of 13. These figures are reported as provided rather than as independently verified live database results. Author records can contain publication-attribution errors, duplicate profiles, and metrics that change over time, making a direct review of the linked author record important for accurate identification and assessment. [1]

Research Contributions

The significance of a researcher’s contributions is best established by examining the substance of individual studies, the problems addressed, the methods employed, and the extent to which the findings advance existing knowledge or professional practice. In Health Professions, relevant contributions may include improvements in healthcare processes, evidence-based practice, professional education, clinical outcomes, or the evaluation of health services. The available profile information does not identify particular studies by Da Fu, so specific discoveries or innovations cannot responsibly be attributed without reviewing the underlying publications.[2]

Publications

The supplied profile reports 15 documents associated with Scopus Author ID 59587646900. A publication-level review is needed to establish the titles, authorship order, publication dates, journal or conference details, and document types represented in this record. These details should be checked against the publisher’s version of record, DOI metadata where available, and the linked bibliographic database before a complete publication list is prepared.[1]

Research Impact

The supplied bibliometric snapshot records 703 citations and an h-index of 13. The h-index is a bibliometric indicator that combines publication productivity with citation frequency: a value of 13 conventionally indicates at least 13 publications with at least 13 citations each within the database and dataset used to calculate it. Citation counts reflect attention from other indexed works, but they do not by themselves measure methodological quality, clinical effectiveness, originality, or wider societal benefit. [2]

Award Suitability

A robust award assessment should consider verified publications, the significance of selected research outputs, evidence of the candidate’s personal contribution, peer recognition, ethical research practices, and relevance to the award’s published criteria. Where applicable, evidence of patents, practical implementation, interdisciplinary collaboration, or measurable benefits to professional practice may provide additional context. The final assessment should follow the organizer’s official requirements and a consistent, documented review process.[1]

Conclusion

The supplied information presents Da Fu as a researcher affiliated with Shanghai Jiao Tong University in China, with a Scopus author identifier and reported bibliometric indicators in Health Professions. The profile offers a starting point for academic recognition and further examination of the researcher’s scholarly record. A complete evaluation of scientific distinction, however, requires verification of identity, affiliation, publications, citation data, and individual research contributions. Combining reliable bibliographic evidence with qualitative expert review provides a more balanced and transparent basis for considering suitability for the Outstanding Scientist Award.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Seetharaman Balaji, Author ID 59587646900
    https://www.scopus.com/authid/detail.uri?authorId=59587646900
  2. National Library of Medicine. (2021. ).microRNA-320b suppresses HNF4G and IGF2BP2 expression to inhibit angiogenesis and tumor growth of lung cancer.
    https://doi.org/10.1093/carcin/bgab023
  3. International Invention Awards. (2026. ). Official award website.
    https://inventionawards.org/

Yun Dai | Medicine and Dentistry | Best Researcher Award

Best Researcher Award

Yun Dai
Chengdu University of Traditional Chinese Medicine

Yun Dai
Affiliation Chengdu University of Traditional Chinese Medicine
Country China
Scopus ID 35726781700
Documents 99
Citations 593
h-index 14
Subject Area Medicine and Dentistry
Event International Invention Awards

Yun Dai is presented in this academic recognition profile as a researcher affiliated with Chengdu University of Traditional Chinese Medicine in China. The supplied Scopus profile records 99 documents, 593 citations and an h-index of 14 in the subject area of Medicine and Dentistry. These bibliometric indicators provide a quantitative snapshot of indexed research output and citation activity. The profile outlines the researcher’s academic context and the relevance of scholarly contributions to consideration for the Best Researcher Award associated with the International Invention Awards. The reported metrics should be verified against the current Scopus record before publication. [1]

Abstract

This article presents an academic profile of Yun Dai, affiliated with Chengdu University of Traditional Chinese Medicine, China, in the field of Medicine and Dentistry. The supplied Scopus metrics indicate 99 indexed documents, 593 citations and an h-index of 14. These indicators offer a quantitative overview of publication output and citation visibility but do not independently establish research quality, originality or practical impact. The profile contextualizes these metrics within consideration for the Best Researcher Award at the International Invention Awards. Further assessment should examine verified publications, methodological rigor, individual contributions, research integrity, innovation and the relevance of findings to scientific knowledge and healthcare practice. [1]

Keywords

Yun Dai; Best Researcher Award; Chengdu University of Traditional Chinese Medicine; Medicine and Dentistry; bibliometric indicators; Scopus author profile; research productivity; citation impact; academic research; scientific innovation; scholarly communication; International Invention Awards.[1]

Introduction

Research recognition programs provide a framework for acknowledging scholarly contributions across academic disciplines. In medicine and related fields, a balanced assessment may consider the significance of research questions, the reliability of methods, publication quality, citation patterns and potential contributions to clinical or scientific practice. Bibliographic databases such as Scopus support the discovery and quantitative assessment of scholarly literature, although database coverage and citation practices vary between disciplines. [1]

Research Profile

The information supplied for this profile identifies Yun Dai as affiliated with Chengdu University of Traditional Chinese Medicine in China, with a subject classification of Medicine and Dentistry. The associated Scopus Author ID is 35726781700. The reported bibliometric snapshot lists 99 documents, 593 citations and an h-index of 14. These figures can help readers locate and evaluate an author’s indexed research record, but they should be checked directly against the linked database because profiles and metrics may change over time. The supplied information does not independently establish academic rank, specific research specialties, professional appointments or the details of individual projects[2]

Research Contributions

Assessing Yun Dai’s research contributions requires examination of the underlying publications, their research questions, methodological quality, findings and relevance to the wider scientific literature. In medicine and dentistry, important considerations may include the robustness of evidence, reproducibility, ethical research conduct and the extent to which results inform further investigation or practice. The supplied document and citation counts indicate a reported level of indexed publication activity, but they do not identify individual discoveries or establish clinical outcomes. A comprehensive evaluation should therefore draw on verified papers, contribution statements and appropriate subject-specific evidence before describing particular innovations or achievements.[3]

Publications

The supplied Scopus data report 99 documents associated with the author identifier provided for Yun Dai. The individual publication titles, author order, publication years, journal names and DOI records have not been independently supplied for this article. Readers should consult the linked Scopus profile to review the indexed bibliography and confirm that records correspond to the intended researcher. For reliable academic reporting, each publication should be checked against its publisher record, and DOI links should be used where available. No specific paper or DOI is attributed to Yun Dai here without a verified bibliographic record. [1]

Research Impact

The reported 593 citations and h-index of 14 offer complementary measures of citation activity in the supplied research profile. The h-index reflects a combination of publication output and citation frequency, while total citations describe the accumulated citations recorded for indexed documents. Neither measure alone captures methodological rigor, societal benefit, clinical relevance or the originality of a research contribution. Citation counts can also be affected by career length, subject conventions, collaboration patterns and database coverage. A balanced impact assessment should combine these indicators with a qualitative review of selected publications, evidence of reproducibility, research translation where applicable and contributions to the scientific community. [2]

Award Suitability

The supplied publication and citation metrics provide relevant preliminary information for considering Yun Dai in connection with the Best Researcher Award at the International Invention Awards. A defensible award assessment should also review the originality and significance of the research, the candidate’s identifiable contribution to collaborative work, publication quality, ethical standards and supporting documentation. The figures presented in this article should not be interpreted as confirmation that an award has been granted or that an independent judging panel has established eligibility. Final suitability and recognition remain subject to the award organizer’s criteria, verification process and official decision. [3]

Conclusion

Yun Dai’s supplied academic profile records an affiliation with Chengdu University of Traditional Chinese Medicine in China and a research classification in Medicine and Dentistry. The reported Scopus metrics—99 documents, 593 citations and an h-index of 14—provide a quantitative starting point for understanding indexed research activity. A complete assessment of scholarly merit requires direct review of the publication record, research quality, individual contributions and wider relevance. This article provides a neutral, preliminary profile associated with the Best Researcher Award and the International Invention Awards, without asserting unverified discoveries, outcomes or award decisions. Bibliometric details should be confirmed against current authoritative records before formal use.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Yun Dai, Author ID 35726781700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35726781700
  2. Journal Article. (2026. ). Dynamic relationship between axial length and crystalline lens during myopic refractive development in children: a 5-year cohort study.
    https://doi.org/10.1038/s41433-026-04538-6
  3. National Library of Medicine. (2026. ) Effect of Chromatic Aberration on White-Light Contrast Sensitivity With Higher-Order Monochromatic Aberrations Correction in the Human Eye in Screen-Based Vision.
    https://doi.org/10.1167/tvst.15.3.17
  4. Research article. (2026. ) The influence of magnification correction on macular retinal/choroidal thickness and vessel density measurements using optical coherence tomography angiography in 4–17-year-old students.
    https://doi.org/10.1016/j.pdpdt.2026.105625
  5. International Invention Awards. (2026. ). Official award website.
    https://inventionawards.org/

Hilary Coon | Medicine and Dentistry | Research Excellence Award

Research Excellence Award

Hilary Coon
University of Utah School of Medicine

Hilary Coon
Affiliation University of Utah School of Medicine
Google Scholar ID RB93YwQAAAAJ&hl=en
Documents 376
Citations 46,313
h-index 87
Subject Area Suicide mortality risk
Event International Invention Awards
ORCID 0000-0002-8877-5446

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Abstract

Hilary Coon is a researcher associated with the University of Utah School of Medicine whose scholarly profile is centered on suicide mortality risk and related population health research. This recognition page presents an overview of the researcher’s academic profile, research focus, scholarly record, and suitability for the Research Excellence Award. The profile data supplied for this article include 376 documents, 46,313 citations, and an h-index of 87. The article places these indicators in context while avoiding claims beyond the supplied information. It also identifies professional links and selected references for readers seeking further information about the researcher and award program.

Keywords

Hilary Coon; Research Excellence Award; University of Utah School of Medicine; suicide mortality risk; psychiatric genetics; suicide research; genetic epidemiology; population health; psychiatric research; scholarly impact.

Introduction

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Research Profile

The supplied academic profile identifies Hilary Coon with the University of Utah School of Medicine. Her stated subject area is suicide mortality risk. University information also lists research interests spanning psychiatry, epidemiology, biomedical informatics, neurobiology, and genetic epidemiology, reflecting an interdisciplinary research orientation and collaboration. [1]

Research Contributions

Coon’s research contributions include collaborative studies examining genetic and clinical factors associated with suicide death, suicidal behavior, and related psychiatric conditions. Recent work has investigated differences among people who die by suicide, including cases without preceding nonfatal suicidal behavior, while other studies examine familial and polygenic risk and relevant evidence. [1] [2]

Publications

The supplied profile reports 376 documents and 46,313 citations, with an h-index of 87. University records list publications across psychiatry, psychiatric genetics, epidemiology, and related biomedical disciplines. Examples include studies of suicide mortality, genetic risk, familial risk, and clinical characteristics associated with suicidal behavior and death in recent scholarly work. [1]

Research Impact

The research program contributes to a broader effort to clarify biological, clinical, and population-level factors associated with suicide mortality. University sources describe the use of Utah research resources and collaborative datasets to investigate complex psychiatric risks. Such work can support evidence development while requiring careful responsible interpretation and ethical consideration. [1]

Award Suitability

The Research Excellence Award is framed around documented scholarly activity, research relevance, publication record, and measurable citation indicators supplied for this profile. Coon’s documented focus on suicide mortality risk and related genetic and epidemiological research provides a coherent academic basis for recognition within a research-oriented award program in academic context. [1]

Conclusion

Hilary Coon’s profile reflects sustained research activity at the intersection of psychiatry, genetics, epidemiology, and suicide mortality research. The supplied bibliometric indicators and documented research focus support presentation as a candidate for the Research Excellence Award. Readers should consult institutional and scholarly sources for publication and profile information and records. [1] [2]

References

  1. ORCID. (n.d.). Hilary Coon, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0002-8877-5446
  2. Coon, H., Shabalin, A. A., DiBlasi, E., et al. (2025). Understanding heterogeneity in suicidal thoughts and behaviours and the implications for genetic studies – a commentary on Lannoy et al. (2022).
    https://doi.org/10.1111/jcpp.13778
  3. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

 

Fruzsina Mezei | Nursing and Health Professions | Innovative Research Award

Innovative Research Award

Fruzsina Mezei
Università Cattolica del Sacro Cuore
Fruzsina Mezei
Affiliation Università Cattolica del Sacro Cuore
Country Italy
Scopus ID 57225091697
Documents 8
Citations 65
h-index 3
Google Scholar JlzScJMAAAAJ&hl
Subject Area Nursing and Health Professions
Event International Invention Awards
ORCID 0000-0001-5924-9781

Fruzsina Mezei is a researcher affiliated with Università Cattolica del Sacro Cuore whose scholarly activities contribute to nursing and health professions research through evidence-based investigation and interdisciplinary collaboration. Her published studies demonstrate engagement with healthcare improvement, scientific methodology, and clinical knowledge development. Indexed academic outputs and measurable citation indicators reflect the visibility of her work within international databases, supporting recognition for sustained contributions to healthcare research and innovation.[1]

Abstract

Fruzsina Mezei has established a developing academic profile within nursing and health professions through research emphasizing evidence-based practice, healthcare quality, and interdisciplinary collaboration. Her indexed publications contribute to scientific understanding by addressing clinically relevant questions and supporting informed healthcare decision-making. Bibliometric indicators demonstrate growing scholarly visibility, while citation performance reflects recognition by the wider research community. Through collaboration with healthcare researchers and institutions, her work promotes methodological rigor, knowledge dissemination, and practical application. These characteristics collectively illustrate an active research trajectory appropriate for academic recognition within international innovation and research award programs.[2]

Keywords

Nursing Research, Health Professions, Clinical Research, Evidence-Based Practice, Healthcare Innovation, Scientific Collaboration, Medical Education, Patient Care, Healthcare Quality, Research Impact.

Introduction

Academic research within nursing and health professions plays an essential role in advancing healthcare quality and improving patient outcomes through systematic investigation. Fruzsina Mezei contributes to this objective by participating in scholarly research that supports evidence generation, encourages interdisciplinary cooperation, and strengthens scientific understanding within healthcare environments while maintaining alignment with internationally recognized research standards.[3]

Research Profile

The research profile of Fruzsina Mezei reflects continued scholarly activity documented within Scopus and supported by measurable publication and citation metrics. Her affiliation with Università Cattolica del Sacro Cuore provides an environment encouraging multidisciplinary collaboration, academic excellence, and meaningful healthcare research addressing clinically relevant challenges across nursing and health professions.[1]

Research Contributions

Her scientific contributions emphasize rigorous investigation, collaborative publication, and dissemination of healthcare knowledge through peer-reviewed research. These studies contribute to understanding healthcare practice, clinical outcomes, and evidence-based approaches while supporting future investigations. Such contributions strengthen academic dialogue and encourage continuous improvements within nursing and related healthcare disciplines internationally.[4]

Publications

The documented publication record includes peer-reviewed journal articles indexed within Scopus, demonstrating consistent engagement with healthcare research. These publications collectively represent scientific productivity and collaboration while contributing evidence to professional literature. Their accessibility through international indexing services enhances discoverability, supports citation growth, and promotes broader academic communication across healthcare research communities.[1]

Research Impact

Research impact may be observed through publication visibility, citation performance, and scholarly engagement within international databases. The available bibliometric indicators demonstrate that Fruzsina Mezei’s work has attracted academic attention and contributes to ongoing scientific discussions. Such measurable outcomes indicate meaningful participation in healthcare research while supporting future collaborative opportunities and continued scientific development.[2]

Award Suitability

Considering documented scholarly productivity, international indexing, measurable citation indicators, and contributions to nursing and health professions, Fruzsina Mezei demonstrates characteristics commonly associated with candidates for research recognition. Her sustained academic engagement, commitment to evidence-based investigation, and collaborative scientific output align appropriately with the objectives of the International Invention Awards and similar research excellence programs.[5]

Conclusion

Fruzsina Mezei maintains a growing academic profile supported by indexed publications, scholarly citations, and interdisciplinary healthcare research. Her documented achievements illustrate meaningful scientific participation and demonstrate continued commitment to advancing nursing and health professions through evidence-based inquiry, making her research profile suitable for professional academic recognition and international visibility.[2]

References

  1. Elsevier. (n.d.). Scopus Author Details: Fruzsina Mezei, Author ID 57225091697.
    https://www.scopus.com/pages/authors/57225091697
  2. ORCID. (n.d.). Fruzsina Mezei ORCID Record.
    https://orcid.org/0000-0001-5924-9781
  3. Journal article. (2022.). Digitális egészségügyi technológiák értékelése – Diabétesz applikációk Németországban.
    https://doi.org/10.53020/IME-2022-207
  4. Journal article. (2021.). Countrywide survey on utilization of medical devices by GPs in Hungary: advantages of the cluster-practice model.
    https://doi.org/10.1017/s1463423621000372
  5. International Invention Awards. (2026.). Official Award Website.
    https://inventionawards.org/

Hamidreza Ghasemirad | Medicine and Dentistry | Young Researcher Award

Young Researcher Award

Hamidreza Ghasemirad
Affiliation Shahid Sadoughi University of Medical Sciences, Yazd
Country Iran
Scopus ID 57720329700
Documents 15
Citations 121
h-index 6
Subject Area Medicine and Dentistry
Event International Invention Awards
ORCID 0000-0002-5390-6653

Hamidreza Ghasemirad

Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Hamidreza Ghasemirad is an emerging researcher affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, whose scholarly activities primarily focus on medicine and dentistry. His publication record, citation performance, and measurable research impact demonstrate consistent academic development during the early stages of his career. These achievements indicate sustained engagement in evidence-based research and interdisciplinary collaboration while contributing to scientific knowledge within healthcare-related disciplines.[1]

Abstract

Hamidreza Ghasemirad has established a developing academic profile through research activities in medicine and dentistry, supported by peer-reviewed publications and measurable citation performance. His scholarly work reflects an emphasis on scientific rigor, collaborative investigation, and evidence-based healthcare research. With fifteen indexed documents, one hundred twenty-one citations, and an h-index of six, his contributions indicate growing recognition within the research community. These accomplishments demonstrate continued engagement with contemporary medical challenges while highlighting the potential for future innovation, interdisciplinary collaboration, and broader international scientific influence through sustained publication and research excellence.[1][2]

Keywords

Medicine, Dentistry, Clinical Research, Healthcare Innovation, Scientific Publications, Citation Impact, Early Career Researcher, Medical Sciences.

Introduction

The advancement of medical science depends on researchers capable of generating reliable evidence while addressing emerging healthcare challenges. Early-career scholars play a significant role by introducing innovative perspectives and expanding interdisciplinary collaboration. Hamidreza Ghasemirad represents this developing generation of researchers through consistent scientific productivity and participation in internationally indexed research activities that contribute to academic progress.[2]

Research Profile

Affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, Hamidreza Ghasemirad has developed a research portfolio centered on medicine and dentistry. His scholarly record demonstrates active participation in peer-reviewed publishing, with research recognized through citations and indexing in international bibliographic databases. These indicators reflect an expanding academic presence and commitment to maintaining recognized standards of scientific quality.[1]

Research Contributions

His research contributions encompass scientific investigations that support evidence-based healthcare and clinical understanding. Through collaborative publications and analytical research methods, he has participated in studies that strengthen medical knowledge while encouraging practical application within healthcare settings. The cumulative influence of these publications demonstrates meaningful engagement with contemporary scientific questions and ongoing academic development.[3]

Publications

The available publication record includes fifteen Scopus-indexed documents spanning medical and dental sciences. These publications reflect participation in peer-reviewed scholarly communication and illustrate a sustained commitment to disseminating research findings through internationally recognized academic platforms. Citation accumulation further indicates that the published work has received attention from researchers working in related scientific disciplines.[1][4]

Research Impact

Research impact is commonly evaluated using citation metrics, publication quality, scholarly visibility, and sustained contribution to scientific advancement. Hamidreza Ghasemirad’s citation record and h-index demonstrate that his work has achieved measurable recognition within the academic community. These indicators suggest continuing influence and provide a foundation for future collaborative and interdisciplinary research opportunities.[2]

Award Suitability

Based on documented publication output, citation performance, and active engagement in medical research, Hamidreza Ghasemirad demonstrates characteristics commonly associated with emerging scientific leadership. His growing academic profile, commitment to peer-reviewed scholarship, and measurable research visibility align well with the objectives of the Young Researcher Award presented during the International Invention Awards, where recognition emphasizes promising scientific achievement and future research potential.[5]

Conclusion

Hamidreza Ghasemirad has established a developing academic profile through consistent scholarly activity in medicine and dentistry. His publication record, citation performance, and institutional affiliation collectively indicate sustained research engagement and continuing professional growth. These achievements provide a strong foundation for future scientific contributions while supporting consideration for academic recognition through international research award programs.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Hamidreza Ghasemirad, Author ID 57720329700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57720329700
  2. ORCID. (n.d.). ORCID Record: Hamidreza Ghasemirad.
    https://orcid.org/0000-0002-5390-6653
  3. Pharmaceutical and Biomedical Research. (2025). Clinical and Prognostic Findings in Psychotropic Substance Poisoning: A Cross-sectional Study.
    https://doi.org/10.32598/pbr.11.3.1366.1
  4. Molecular and Cellular Biochemistry. (2023). The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer.
    https://doi.org/10.1007/s11010-023-04790-4
  5. International Invention Awards. (n.d.). Award Information and Recognition Program.
    https://inventionawards.org/

Leticia Szadai | Medicine and Dentistry | Best Researcher Award

Best Researcher Award

Leticia Szadai
Lund University, Sweden

Leticia Szadai
Affiliation Lund University
Country Sweden
Google Scholar ID CNcrXOIAAAAJ
Documents 27
Citations 175
h-index 7
Subject Area Medicine and Dentistry
Event International Invention Awards

The Best Researcher Award recognizes researchers whose scholarly activities have contributed to the advancement of knowledge and innovation within their respective disciplines. Leticia Szadai of Lund University has developed a research profile centered on melanoma biology, proteomics, biomarker discovery, and translational cancer research. Her work integrates advanced molecular analysis with clinical applications, supporting improved understanding of melanoma progression, recurrence mechanisms, and therapeutic opportunities. Through collaborative research efforts, she has contributed to the generation of valuable datasets and analytical frameworks relevant to modern oncology research.[1]

Abstract

This article summarizes the academic achievements and research contributions of Leticia Szadai. Her work primarily focuses on melanoma proteomics, molecular pathology, biomarker identification, and translational oncology. Through participation in multidisciplinary investigations, she has contributed to the development of proteomic resources and analytical methods that support precision medicine approaches in cancer research.[2]

Keywords

Melanoma, Proteomics, Molecular Pathology, Biomarkers, Translational Medicine, Cancer Research, Precision Oncology, Tumor Biology.

Introduction

Advances in cancer research increasingly depend on interdisciplinary methodologies that connect molecular science with clinical practice. Leticia Szadai has contributed to this field through studies examining melanoma biology and the molecular factors associated with disease progression and recurrence. Her research reflects contemporary efforts to improve diagnostic and prognostic strategies through large-scale proteomic investigation.[3]

Research Profile

As a researcher affiliated with Lund University, Leticia Szadai has participated in projects involving molecular oncology, clinical proteomics, and translational medicine. Her publication record demonstrates engagement with collaborative international research initiatives focused on melanoma tissue analysis, mitochondrial regulation, immune response mechanisms, and biomarker discovery. These efforts contribute to the broader objective of enhancing evidence-based cancer management.[4]

Research Contributions

  • Contributed to studies establishing comprehensive melanoma proteome atlases.
  • Investigated molecular pathology and protein expression patterns in melanoma.
  • Explored mitochondrial dysfunction and immune response dysregulation associated with melanoma recurrence.
  • Participated in biomarker discovery using archived tumor samples and advanced proteomic technologies.
  • Supported research into kinase signaling pathways and translational applications in oncology.

Publications

  • The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome (2021).
  • The Human Melanoma Proteome Atlas—Defining the Molecular Pathology (2021).
  • Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence (2023).
  • Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out (2021).
  • A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma (2021).

Research Impact

The available citation metrics indicate that Leticia Szadai’s research outputs have attracted scholarly attention within oncology and translational medicine communities. Her involvement in high-impact collaborative studies has supported the development of proteomic resources that facilitate future investigations into melanoma progression, biomarker validation, and personalized therapeutic strategies. These contributions demonstrate measurable academic influence and continuing relevance to cancer research.[5]

Award Suitability

Leticia Szadai’s research portfolio aligns with the objectives of the International Invention Awards and the Best Researcher Award category. Her scholarly contributions reflect innovation in proteomic methodology, translational cancer research, and biomarker development. The combination of publication activity, collaborative leadership, and clinically relevant outcomes supports recognition for contributions to medicine and dentistry-related scientific advancement.[6]

Conclusion

Leticia Szadai has established a research profile characterized by rigorous investigation of melanoma biology and proteomics. Her contributions to translational oncology, biomarker discovery, and molecular pathology have supported scientific understanding of cancer mechanisms and potential clinical applications. These achievements provide a strong foundation for academic recognition through the Best Researcher Award.

References

  1. Elsevier. (n.d.). Google Scholar author details: Leticia Szadai
    https://scholar.google.com/citations?hl=hu&user=CNcrXOIAAAAJ
  2. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.451
  3. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Defining the Molecular Pathology. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.473
  4. Szadai L et al. (2023). Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.1495
  5. Szadai L et al. (2021). Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out. Cancers.
    https://doi.org/10.3390/cancers13236105
  6. Velasquez E et al. (2021). A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.466

A. Marcell Szasz | Medicine and Dentistry | Excellence in Research Award

Excellence in Research Award

A. Marcell Szasz
Semmelweis University, Hungary

A. Marcell Szasz
Affiliation Semmelweis University
Country Hungary
Scopus ID 24723204500
Documents 147
Citations 4,107
h-index 29
Subject Area Medicine and Dentistry
Event International Invention Awards
Google Scholar ID eeJzLNQAAAAJ

The Excellence in Research Award recognizes researchers whose scholarly activities demonstrate sustained contributions to scientific advancement, interdisciplinary collaboration, and measurable research impact. A. Marcell Szasz of Semmelweis University has developed a notable academic profile in medicine and cancer research through influential publications, biomarker studies, translational oncology investigations, and evidence-based clinical analyses.[1] His publication record and citation performance indicate significant engagement within the international scientific community.[2]

Abstract

A. Marcell Szasz has contributed to the fields of oncology, molecular medicine, prognostic biomarker analysis, and cancer outcome prediction. His research portfolio encompasses gene-expression studies, clinical meta-analyses, cancer progression modeling, and translational medical investigations. Through collaborations with international research teams, his work has informed understanding of disease mechanisms and patient stratification approaches in modern oncology.[2]

Keywords

Oncology, Biomarkers, Precision Medicine, Cancer Research, Meta-analysis, Gene Expression, Translational Medicine, Clinical Research.

Introduction

Research excellence is frequently evaluated through scientific influence, publication quality, citation impact, and contribution to knowledge development. Within this context, A. Marcell Szasz has established a scholarly presence through studies addressing cancer biology, prognostic biomarkers, and therapeutic outcomes. His work contributes to evidence-based approaches used in clinical and translational medicine.[3]

Research Profile

The researcher maintains a substantial publication portfolio consisting of 147 indexed documents, more than 4,100 citations, and an h-index of 29. His academic activity is primarily associated with medicine, oncology, pathology, molecular diagnostics, and clinical outcome assessment. These metrics reflect both productivity and sustained visibility within international scientific literature.[1]

Research Contributions

  • Investigation of microRNA regulation and metastatic progression in breast cancer.
  • Development and validation of transcriptomic biomarkers associated with survival outcomes.
  • Comprehensive meta-analyses supporting clinical decision-making in oncology.
  • Studies examining genomic alterations and evolutionary pathways of metastatic disease.

Publications

Among his most cited publications are studies on miR-31 and breast cancer metastasis, transcriptomic biomarker validation in gastric cancer, urachal carcinoma meta-analysis, tamoxifen-response biomarkers, and phylogenetic analyses of metastatic progression.[4] These works have received substantial scholarly attention and have been referenced extensively in subsequent research.

Research Impact

The citation performance associated with A. Marcell Szasz demonstrates broad engagement from researchers across oncology, pathology, molecular biology, and clinical medicine. His publications have contributed to methodological refinement, biomarker validation, and evidence synthesis efforts that support future investigations and clinical translation.[5]

Award Suitability

The Excellence in Research Award emphasizes scientific rigor, research influence, and sustained scholarly contribution. Based on publication metrics, citation impact, interdisciplinary collaborations, and documented contributions to cancer research, A. Marcell Szasz demonstrates characteristics commonly associated with distinguished academic achievement and research leadership.[6]

Conclusion

A. Marcell Szasz has contributed meaningfully to contemporary oncology research through studies addressing biomarkers, disease progression, and clinical outcomes. His publication record, citation profile, and participation in influential collaborative projects provide a strong foundation for recognition within an academic award framework focused on research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: A. Marcell Szasz, Author ID 24723204500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24723204500
  2. Valastyan S., Reinhardt F., et al. (2009). miR-31 inhibits breast cancer metastasis. Cell.
    DOI: https://doi.org/10.1016/j.cell.2009.03.047
  3. Szász A.M., Lánczky A., et al. (2016). Cross-validation of survival associated biomarkers in gastric cancer. Oncotarget.
    DOI: https://doi.org/10.18632/oncotarget.10337
  4. Brown D., Smeets D., Székely B., Szasz A.M., et al. (2017). Phylogenetic analysis of metastatic progression in breast cancer. Nature Communications.
    DOI: https://doi.org/10.1038/ncomms14944
  5. Mihály Z., Kormos M., Lánczky A., et al. (2013). Gene expression-based biomarkers predicting outcome after tamoxifen treatment.
    DOI: https://doi.org/10.1007/s10549-013-2619-y
  6. Szarvas T., Módos O., Niedworok C., et al. (2016). Clinical, prognostic, and therapeutic aspects of urachal carcinoma.
    DOI: https://doi.org/10.1016/j.urolonc.2016.04.012

John Dundon | Medicine and Dentistry | Research Excellence Award

Dr. John Dundon | Medicine and Dentistry | Research Excellence Award 

Orthopedic Research Institute of New Jersey | United States

Dr. John M. Dundon is a board-certified orthopedic surgeon and clinician–scientist with a distinguished research profile focused on adult reconstruction, total hip and knee arthroplasty, surgical innovation, and value-based orthopedic care. As a Full Partner at Tri-County Orthopedics and previously at the Orthopedic Institute of New Jersey, Dr. Dundon combines high-volume clinical practice with impactful academic research aimed at improving surgical precision, patient outcomes, and healthcare efficiency in joint replacement surgery. A central theme of Dr. Dundon’s research is the optimization of total joint arthroplasty through advanced technologies, including computer-assisted navigation, imageless systems, and smart implants. His work has demonstrated that navigation-assisted techniques significantly improve component positioning accuracy in complex primary and revision total hip arthroplasty, directly contributing to reduced complications, improved biomechanics, and better long-term implant survival. He has also explored objective gait analysis using smart implants, showing how real-time data can guide early postoperative interventions and enhance functional recovery following total knee arthroplasty. Dr. Dundon has made notable contributions to perioperative care pathways and health systems research. His studies on multimodal pain management protocols have shown that opioid use, patient-controlled analgesia, and femoral nerve blocks can be safely reduced or eliminated without compromising patient comfort, aligning surgical practice with modern opioid-sparing strategies. Additionally, his work on bundled payment models and quality metrics has provided evidence that structured care initiatives can significantly improve outcomes while reducing readmissions and healthcare costs. The development of the Readmission Risk Assessment Tool (RRAT) further highlights his commitment to predictive analytics and patient optimization in arthroplasty. His research portfolio also addresses implant biomechanics, tribocorrosion, femoral stem sizing, leg-length discrepancy correction, and postoperative imaging utilization, reflecting a comprehensive approach to both technical and clinical challenges in orthopedic surgery. Dr. Dundon has authored influential review articles and textbook chapters, including contributions to Orthopedic Knowledge Update and The Adult Hip, which serve as key references for practicing surgeons and trainees worldwide. With an extensive record of peer-reviewed publications, national and international presentations, and leadership roles within major orthopedic societies such as the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons, Dr. Dundon is widely recognized for bridging evidence-based research and clinical excellence. His research profile reflects sustained innovation, interdisciplinary collaboration, and a clear commitment to advancing the safety, effectiveness, and value of modern joint replacement surgery.

Citation Metrics (Scopus)

1000
600
400
200
50
0

Citations
641

i10index
20

h-index
9

Citations

i10-index

h-index

View Scopus Profile

Featured Publications

Gabriella Teresa Capolupo | Medicine and Dentistry | Excellence in Research Award

Dr. Gabriella Teresa Capolupo | Medicine and Dentistry | Excellence in Research Award

Dr. Gabriella Teresa Capolupo | Università campus bio medico di Roma | Italy

Gabriella Teresa Capolupo is an accomplished surgeon, researcher, and academic with extensive expertise in general, oncological, and digestive surgery. She has built a distinguished career that integrates advanced clinical practice with dedicated teaching and scientific contributions. As a university lecturer and instructor, she actively contributes to academic programs in General Surgery, Urology, Digestive Surgery, Endocrinology and Metabolic Surgery, Emergency Surgery, and Head and Neck Surgery. Her educational roles include formal teaching, clinical tutoring, multidisciplinary course integration, and participation in advanced training initiatives such as postgraduate master programs and summer schools. She also serves as coordinator of the tutoring activities for the School of Specialization in General Surgery, ensuring high-quality mentorship for surgical trainees and supporting their academic and clinical progression. Her academic profile is further strengthened by appointments to evaluation bodies, including doctoral examination committees in translational medicine and oncology. Clinically, Dr. Capolupo’s work is rooted in continuous service at a major university hospital, where she has operated within colorectal, general, and geriatric surgery units. She performs a broad range of surgical procedures with recognized expertise in abdominal oncological surgery using both laparotomic and laparoscopic approaches. Her responsibilities include acting as first surgeon, surgical assistant, and tutor in the operating room, as well as leading emergency surgical teams. She has held roles with functional leadership responsibilities across both permanent and fixed-term appointments. Her research activity is substantial and internationally recognized, with 2,050 citations, 105 scientific documents, and an h-index of 19, reflecting her influence and scholarly impact in the field of surgical sciences. Dr. Capolupo’s professional trajectory demonstrates a strong and consistent commitment to clinical excellence, scientific advancement, and the training of future medical professionals.

Profiles: Scopus | Orcid

Featured Publications

Schiavone, V., Carannante, F., Melone, G., Miacci, V., Costa, G., Taffon, C., Caricato, M., Capolupo, G. T., & Mascianà, G. (2025). Tailoring the management of colonic lipomas: A 10-year experience of surgical and endoscopic resection. Journal of Personalized Medicine, 15(11), 544. https://doi.org/10.3390/jpm15110544

Schiavone, V., Capolupo, G. T., Mascianà, G., Carannante, F., Costa, G., Miacci, V., & Caricato, M. (2025). Non-operative management (NOM) in rectal cancer: Current evidence and future directions. Encyclopedia, 5(4), 165. https://doi.org/10.3390/encyclopedia5040165

Carannante, F., Capolupo, G. T., Barberio, M., Altamura, A., Miacci, V., Scopigno, M. Z., Circhetta, E., Costa, G., Caricato, M., & Viola, M. G. (2024). Evaluation of short-term effects on colorectal surgery elective patients after implementing a patient blood management program: A multicenter retrospective analysis. Journal of Clinical Medicine, 13(15), 4447. https://doi.org/10.3390/jcm13154447

Feola, A., Minotti, C., Marchetti, D., Caricato, M., Capolupo, G. T., Marsella, L. T., & La Monaca, G. (2021). A five-year survey for plastic surgery malpractice claims in Rome, Italy. Medicina, 57(6), 571. https://doi.org/10.3390/medicina57060571

Mascianà, G., Capolupo, G. T., Carannante, F., & Caricato, M. (2019). An omental mass. Any idea? International Journal of Surgery Case Reports, 57, 161–164. https://doi.org/10.1016/j.ijscr.2019.02.019

Catarci, M., Ruffo, G., Borghi, F., Patriti, A., Delrio, P., Scatizzi, M., Mancini, S., Garulli, G., Carrara, A., Pirozzi, F., et al. (2019). Colorectal surgery in Italy: A snapshot from the iCral study group. Updates in Surgery, 71, 515–524. https://doi.org/10.1007/s13304-018-00612-1

Carannante, F., Mascianà, G., Lauricella, S., Caricato, M., & Capolupo, G. T. (2019). Correction to: Skin bridge loop stoma: Outcome in 45 patients in comparison with stoma made on a plastic rod. International Journal of Colorectal Disease, 34(12), 2195–2197. https://doi.org/10.1007/s00384-019-03451-7

Shibel Ageel | Medicine | Best Researcher Award

Dr. Shibel Ageel | Medicine | Best Researcher Award 

Dr. Shibel Ageel | Faculty of Medicine Novi Sad | Croatia

Dr. Shibel Ageel is a dedicated and multilingual medical doctor educated at the Medical Faculty of Novi Sad, University of Novi Sad, graduating in June 2024 as one of the top-ranking students. He has gained broad and diverse clinical experience across Croatia, Serbia, and Tunisia, completing rotations in otorhinolaryngology and head and neck surgery, plastic and reconstructive surgery, general and abdominal surgery, and demonstrating strong technical and diagnostic skills consistently praised by senior surgeons. His passion for surgery, research, and teaching is evident through active participation and poster presentations at numerous medical conferences, including the Osijek Student Congress (OSCON 2020–2024), SaMED 2020 in Sarajevo, and IMSCNS 2019 in Novi Sad. Dr. Ageel has authored and co-authored five peer-reviewed publications including studies and case reports in the MDPI Journal and other indexed medical journals, covering topics such as septoplasty outcomes, fetal tuberous sclerosis, gastric trichobezoars, uterine prolapse, and prurigo diabeticorum. His research bridges surgical innovation and clinical case documentation, contributing valuable insights into ENT and surgical case management. Recognized for his excellence, he received multiple awards including Best Poster Presentation at OSCON 2023, Best Conference Ambassador at OSCON 2024, and a City of Osijek Scholarship for academic distinction. Certified in Basic Life Support (2018) and Advanced Life Support (2024) by the European Resuscitation Council, he combines clinical competence with academic rigor and communication skills. His publications have collectively received growing scholarly recognition with 35 citations in indexed databases and an h-index of 2, reflecting his early yet impactful research trajectory. Driven by curiosity, empathy, and intercultural competence, Dr. Ageel continues to advance in the medical field through clinical excellence, patient-centered care, and research that integrates evidence with global medical collaboration.

Profile: Orcid 

Featured Publications

Tomljenovic, D., Grguric, L., Knežević, M., Svetina, L., Geber, G., Vagic, D., Shibel, A., & Kosec, A. (2025). Comparing nasal patency outcomes in patients undergoing septoplasty with radiofrequency turbinate reduction, turbinectomy, or valvuloplasty: A prospective cohort study. Medicina, 61(9), 1656.